胃食道逆流性疾病的非连续治疗是时候了吗?
Steve D'Souza1, Sharon Udemba1, Ronnie Fass1
1The Esophageal and Swallowing Center, Division of Gastroenterology and Hepatology, MetroHealth System and Case Western Reserve University, Cleveland, Ohio.
Gastroenterology & hepatology
|August 28, 2024
概括
质子抑制剂 (PPI) 是GERD的标准药物,但需要每天使用. 竞争性酸阻断剂 (P-CABs) 显示出由于其快速作用,有望为方便的,非连续的GERD治疗提供希望.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃食道逆流性疾病 (GERD) 是一种慢性疾病,具有显著的长期并发症.
- 质子抑制剂 (PPI) 是主要的治疗方法,但需要每天服用.
- 非连续治疗为患者提供了方便和成本效益.
研究的目的:
- 审查GERD非连续治疗的证据.
- 为了比较PPI和竞争性酸阻断剂 (P-CABs) 对非连续的GERD治疗的适用性.
主要方法:
- 在非连续的GERD治疗中对PPI和P-CAB的当前证据的审查.
- 分析与非连续服药相关的药物特征 (例如,作用速度,耐久性).
主要成果:
- 个人防护剂是有效的,但由于按需治疗的缓慢发作而受到限制.
- 对于非连续的GERD治疗,P-CABs具有有利的药理动力学和药理动力学特征.
- 早期研究表明,P-CABs对非连续的GERD治疗有希望.
结论:
- 不连续治疗对于精选的GERD患者来说是一个可行的选择.
- 与PPI相比,P-CABs代表了非连续GERD治疗的潜在优越选择.
- 需要进一步的研究来证实P-CABs在非连续GERD治疗中的长期价值.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
62
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
62
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
298
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
298
Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
415
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
415
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
361
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
361
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
334
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
334


